Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials
BackgroundImmune-mediated kidney diseases involve the immune system attacking the kidneys, resulting in damage and dysfunction. Tripterygium glycosides (TG) are known for their strong immunosuppressive and anti-inflammatory effects and are commonly used alongside traditional immunosuppressive agents...
Saved in:
| Main Authors: | Yaotan Li, Jinyi Hou, Xiaochang Wu, Chang Liu, Mengqi Zhou, Shijia Lin, Weijing Liu, Yaoxian Wang, Huijuan Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1525482/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models
by: Bidan Zheng, et al.
Published: (2023-12-01) -
Effectiveness of rehmannia glutinosa combined with tripterygium glycosides in treatment of idiopathic membranous nephropathy and prognostic analysis
by: GUO Bo-hui, et al.
Published: (2019-01-01) -
Kidney diseases and single-cell sequencing research: a bibliometric analysis from 2015 to 2024
by: Yaotan Li, et al.
Published: (2025-12-01) -
Efficacy and safety of tripterygium glycosides combined with ACEI/ARB on diabetic nephropathy: a meta-analysis
by: Zhuan’E. Yao, et al.
Published: (2025-01-01) -
Meta-analysis of efficacy and safety of multi-glycoside of Tripterygium wilfordii in the treatment of idiopathic membranous nephropathy
by: YIN Song-jiang, et al.
Published: (2016-01-01)